These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6881119)

  • 1. Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy.
    Uribe M; García-Ramos G; Ramos M; Valverde C; Márquez MA; Farca A; Guevara L
    Am J Gastroenterol; 1983 Aug; 78(8):517-22. PubMed ID: 6881119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.
    Uribe M; Farca A; Márquez MA; Garcĭa-Ramos G; Guevara L
    Gastroenterology; 1979 Jun; 76(6):1347-51. PubMed ID: 374177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactose enemas plus placebo tablets vs. neomycin tablets plus starch enemas in acute portal systemic encephalopathy. A double-blind randomized controlled study.
    Uribe M; Berthier JM; Lewis H; Mata JM; Sierra JG; García-Ramos G; Ramírez Acosta J; Dehesa M
    Gastroenterology; 1981 Jul; 81(1):101-6. PubMed ID: 7239110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine to treat "intractable" portal systemic encephalopathy.
    Uribe M
    Gastroenterology; 1980 Sep; 79(3):602-3. PubMed ID: 7429126
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromocriptine for chronic portal systemic encephalopathy.
    Marzio L; Lanfranchi GA
    Gastroenterology; 1980 Jun; 78(6):1661-2. PubMed ID: 7372089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lactilol (Importal, 10g in powder made by ZYMA) in the treatment of portal systemic encephalopathy].
    Boca M; Duris I; Kolibás E; Kratochvíl'ová E
    Vnitr Lek; 1996 Apr; 42(4):234-8. PubMed ID: 8693708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.
    Morgan MY; Jakobovits AW; James IM; Sherlock S
    Gastroenterology; 1980 Apr; 78(4):663-70. PubMed ID: 7353752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine and premenstrual tension: a clinical and hormonal study.
    Andersch B; Hahn L
    Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic nature of bromocriptine therapy in portal systemic encephalopathy.
    Schenker S; Desmond PV; Speeg KV; Hoyumpa AM
    Gastroenterology; 1980 May; 78(5 Pt 1):1094-7. PubMed ID: 6103858
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.
    Pedretti G; Calzetti C; Missale G; Fiaccadori F
    Ital J Gastroenterol; 1991 May; 23(4):175-8. PubMed ID: 1751811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milk protein in the treatment of chronic portasystemic encephalopathy. A long-term study of therapeutic measures in a patient with chronic porta-systemic encephalopathy.
    Van Der Zwan JC; Gips CH; Qué GS; Boonstra S
    Neth J Med; 1974; 17(2):42-9. PubMed ID: 4839373
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy.
    Morgan MY; Jakobovits A; Elithorn A; James IM; Sherlock S
    N Engl J Med; 1977 Apr; 296(14):793-4. PubMed ID: 576493
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
    Quero Guillén JC; Carmona Soria I; García Montes JM; Jiménez Sáenz M; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2003 Feb; 95(2):135-42, 127-34. PubMed ID: 12760720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
    Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
    Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.